Cargando…

SARS-CoV-2 transmission, persistence of immunity, and estimates of Omicron’s impact in South African population cohorts

Understanding the build-up of immunity with successive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and the epidemiological conditions that favor rapidly expanding epidemics will help facilitate future pandemic control. We analyzed high-resolution infection and serology data...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Kaiyuan, Tempia, Stefano, Kleynhans, Jackie, von Gottberg, Anne, McMorrow, Meredith L, Wolter, Nicole, Bhiman, Jinal N., Moyes, Jocelyn, du Plessis, Mignon, Carrim, Maimuna, Buys, Amelia, Martinson, Neil A, Kahn, Kathleen, Tollman, Stephen, Lebina, Limakatso, Wafawanaka, Floidy, du Toit, Jacques D., Gómez-Olivé, Francesc Xavier, Mkhencele, Thulisa, Viboud, Cécile, Cohen, Cheryl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161370/
https://www.ncbi.nlm.nih.gov/pubmed/35638937
http://dx.doi.org/10.1126/scitranslmed.abo7081
Descripción
Sumario:Understanding the build-up of immunity with successive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and the epidemiological conditions that favor rapidly expanding epidemics will help facilitate future pandemic control. We analyzed high-resolution infection and serology data from two longitudinal household cohorts in South Africa to reveal high cumulative infection rates and durable cross-protective immunity conferred by prior infection in the pre-Omicron era. Building on the history of past exposures to different SARS-CoV-2 variants and vaccination in the more representative urban cohort given South Africa’s high urbanization rate, we used mathematical models to explore the fitness advantage of the Omicron variant and its epidemic trajectory. Modelling suggests the Omicron wave likely infected a large fraction (44% - 81%) of the population, leaving a complex landscape of population immunity primed and boosted with antigenically distinct variants. We project that future SARS-CoV-2 resurgences are likely under a range of scenarios of viral characteristics, population contacts, and residual cross-protection.